STOCK TITAN

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

cbdMD (NYSE American: YCBD) will host a conference call on Friday, December 19, 2025 at 4:20 p.m. ET to discuss its September 30, 2025 fourth quarter and fiscal year 2025 financial results and business progress.

Investors in the USA/Canada can join by phone at 888-880-3330. A live webcast and replay are available via the provided link and will remain accessible through December 19, 2026.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 40 Alerts

+58.74% News Effect
+54.5% Peak in 29 hr 19 min
+$8M Valuation Impact
$23M Market Cap
7.3x Rel. Volume

On the day this news was published, YCBD gained 58.74%, reflecting a significant positive market reaction. Argus tracked a peak move of +54.5% during that session. Our momentum scanner triggered 40 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $8M to the company's valuation, bringing the market cap to $23M at that time. Trading volume was exceptionally heavy at 7.3x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference call date December 19, 2025 Fourth quarter and fiscal 2025 results call
Conference call time 4:20 p.m. Eastern Time Scheduled start time for results discussion
Replay availability Through December 19, 2026 Webcast replay window
Dial-in number 888-880-3330 USA/Canada conference call access

Market Reality Check

$1.37 Last Close
Volume Volume 149,861,345 is 5.32x the 20-day average of 28,143,173 shares. high
Technical Price 2.27 is trading above the 200-day MA at 1.14.

Peers on Argus 3 Up

YCBD gained 58.74% with elevated volume, while key peers showed mixed moves: CPHI -6.62%, SBFM -0.7%, SNOA +5.03%, BFRI -6.36%, EVOK +0.18%. Momentum scanner peers (BFRI, INM, IMCC) were all moving up, highlighting YCBD’s move as stock-specific rather than sector-driven.

Historical Context

Date Event Sentiment Move Catalyst
Dec 08 Listing compliance update Positive +4.7% Regained full compliance with NYSE American listing standards.
Dec 08 Listing compliance update Positive +4.7% Duplicate event noting removal of the “.BC” indicator.
Nov 21 Prelim fiscal 2025 results Positive -6.7% Preliminary results with improved net loss and stable net sales.
Nov 21 Prelim fiscal 2025 results Positive -6.7% Duplicate preliminary results release with same financial trends.
Oct 22 Product expansion Positive -5.7% Expansion of Herbal Oasis THC-infused seltzer lineup with new flavors.
Pattern Detected

Stock often shows mixed or negative reactions around operational and product updates, with occasional positive alignment on regulatory milestones.

Recent Company History

Over the last few months, cbdMD reported preliminary fiscal 2025 results indicating net sales near prior-year levels but an improved net loss, and expanded its Herbal Oasis THC-infused seltzer line on Oct 22, 2025. The company also regained full compliance with NYSE American listing standards, removing the “.BC” flag on Dec 8, 2025. Today's earnings conference-call announcement follows these operational and listing milestones, continuing a pattern of frequent financial and product updates.

Market Pulse Summary

The stock surged +58.7% in the session following this news. A strong positive reaction aligns with the stock’s elevated pre-call positioning but far exceeds the average 6.44% move seen on prior earnings-conference announcements. With shares up 58.74% and trading above the 200-day MA, past divergence around operational news suggests that post-call details have often reset expectations, which could influence how durable such spikes proved historically.

Key Terms

webcast technical
"Webcast/Webcast Replay link - available through December 19, 2026"
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Friday, December 19, 2025, to discuss the company's September 30, 2025 fourth quarter and fiscal year 2025 financial results and business progress.

CONFERENCE CALL DETAILS

Friday, December 19, 2025, 4:20 p.m. Eastern Time

USA/Canada: 888-880-3330

Webcast/Webcast Replay link - available through December 19, 2026:

https://app.webinar.net/13voDmbBlxj

About cbdMD, Inc.

cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cbdmd-inc-to-host-conference-call-to-discuss-september-30-2025-fourth-quarter-and-fiscal-year-2025-results-302645275.html

SOURCE cbdMD, Inc.

FAQ

When will cbdMD (YCBD) discuss its Q4 and fiscal 2025 results?

The company will host a conference call on December 19, 2025 at 4:20 p.m. ET.

How can investors join the cbdMD (YCBD) conference call on December 19, 2025?

Dial 888-880-3330 for USA/Canada access or use the company's webcast link.

Where can I find the cbdMD (YCBD) webcast replay for the December 19, 2025 call?

The webcast/replay is available at the provided webinar link and will be accessible through December 19, 2026.

What topics will cbdMD (YCBD) cover during the December 19, 2025 call?

The call will discuss the September 30, 2025 fourth quarter and fiscal year 2025 financial results and business progress.

Is there a ticker symbol for cbdMD to reference when checking market reaction?

Yes, cbdMD trades on the NYSE American under the symbol YCBD.
Cbdmd Inc

NYSE:YCBD

YCBD Rankings

YCBD Latest News

YCBD Latest SEC Filings

YCBD Stock Data

13.47M
7.54M
16.09%
5.44%
0.97%
Drug Manufacturers - Specialty & Generic
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
CHARLOTTE